- $1.07bn
- $1.36bn
- $441.33m
U.S. STOCKS ON THE MOVE-Celanese, CRH, Symbotic
Artivion Inc reports results for the quarter ended in September - Earnings Summary
Brief: Artivion Q3 Revenue USD 87.854 Million Vs. IBES Estimate USD 84.3 Million
Artivion Inc expected to post a loss of 6 cents a share - Earnings Preview
Artivion Inc reports results for the quarter ended in June - Earnings Summary
Brief: Artivion Q2 Revenue USD 89.251 Million Vs. IBES Estimate USD 84.2 Million
Artivion Inc expected to post a loss of 8 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Galecto, Pinterest, Standard Lithium
U.S. STOCKS ON THE MOVE-Chevron, Broadcom, Williams-Sonoma
Artivion up on FDA device marketing approval in transfer of PerClot to Baxter
Brief: Artivion Announces FDA PMA Approval Of PerClot And Transfer Of PMA To Baxter
Artivion Inc reports results for the quarter ended in March - Earnings Summary
Brief: Artivion Q1 revenue USD 83.229 million
Artivion Inc expected to post a loss of 12 cents a share - Earnings Preview
Brief: Artivion Reports Fourth Quarter And Full Year 2022 Financial Results
Artivion Inc reports results for the quarter ended in December - Earnings Summary
Artivion Inc expected to post a loss of 12 cents a share - Earnings Preview
NYSE ORDER IMBALANCE 105412.0 SHARES ON BUY SIDE
Artivion Inc reports results for the quarter ended in September - Earnings Summary